MARKET

APHA

APHA

Aphria Inc
NYSE

Real-time Quotes | Nasdaq Last Sale

2.955
+0.095
+3.32%
Opening 12:08 04/02 EDT
OPEN
2.870
PREV CLOSE
2.860
HIGH
3.030
LOW
2.810
VOLUME
2.28M
TURNOVER
--
52 WEEK HIGH
10.17
52 WEEK LOW
1.950
MARKET CAP
788.97M
P/E (TTM)
-11.6706
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average APHA stock price target is 6.57 with a high estimate of 7.50 and a low estimate of 5.64.

EPS

APHA News

More
  • High Tide Reports First Quarter 2020 Financial Results Featuring 173% Revenue Increase over the Same Period of the Previous Year
  • CNW Group · 2d ago
  • Hexo and Cronos Reported Earnings, and These Pot Stocks Reacted Very Differently
  • Barrons.com · 2d ago
  • Earnings Reports for the Week of March 30-April 3 (CHWY, MKC, WBA)
  • Kiplinger · 5d ago
  • Pot stocks side step broad market selloff
  • Seeking Alpha - Article · 6d ago

Industry

Pharmaceuticals
+1.36%
Pharmaceuticals & Medical Research
+1.62%

Hot Stocks

Symbol
Price
%Change

About APHA

Aphria Inc is a Canada-based cannabis company. The Company through its Aphria One facility, produces and sells medical and adult-use cannabis and cannabis-derived extracts in Canada under the provisions of the Cannabis Act. Through its subsidiary Broken Coast Cannabis Ltd it operates a licensed indoor cannabis production facility on Vancouver Island.
More

Webull offers kinds of Aphria Inc stock information, including NYSE:APHA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APHA stock news, and many more online research tools to help you make informed decisions.